• TechCrunch
• CrunchBase
• More
  • TechCrunch Europe
  • TechCrunch France
  • TechCrunch Japan

SR One

edit

SR One is the corporate venture capital arm of GlaxoSmithKline. The firm invests globally in emerging life science companies that are pursuing innovative science which will significantly impact medical care. Since 1985, SR One has invested approximately $600 million in more than 130 companies. For more information please visit www.srone.com

Recent Milestones

edit

• 
  SR One invested in Effector Therapeutics. (5/20/13)
  Posted 5/20/13 at 5:21am via fiercebiotech.com
• 
  SR One invested in Aileron Therapeutic. (1/14/13)
  Posted 1/14/13 at 7:06pm via finsmes.com
• 
  SR One invested in River Vision Development. (12/12/12)
  Posted 12/13/12 at 2:38am via prnewswire.com
• 
  SR One invested in Bicycle Therapeutics. (12/10/12)
  Posted 12/11/12 at 5:39am via finsmes.com
• 
  SR One invested in Applied Genetics Technologies Corporation. (11/19/12)
  Posted 11/20/12 at 4:36am via biospace.com
• 
  SR One invested in Principia BioPharma. (10/29/12)
  Posted 10/29/12 at 7:59pm via bizjournals.com
• 
  SR One invested in Thrasos. (10/25/12)
  Posted 10/25/12 at 7:50pm via businesswire.com
• 
  SR One invested in Genocea Biosciences. (10/10/12)
  Posted 10/10/12 at 7:37pm via masshightech.com
• 
  SR One invested in IlluminOss Medical. (9/27/12)
  Posted 9/27/12 at 7:51pm via marketwire.com
• 
  SR One invested in Auxogyn. (6/5/12)
  Posted 6/5/12 at 6:08pm via finsmes.com
• 
  SR One invested in RaNA Therapeutics. (1/18/12)
  Posted 1/18/12 at 3:57am via masshightech.com
• 
  SR One invested in MISSION Therapeutics. (8/25/11)
  Posted 8/25/11 at 7:36pm via biospace.com
• 
  SR One invested in Nimbus Discovery. (6/28/11)
  Posted 6/28/11 at 4:06am via xconomy.com
• 
  SR One invested in HTG Molecular Diagnostics. (6/13/11)
  Posted 6/13/11 at 6:49pm via finsmes.com
• 
  SR One invested in Constellation Pharmaceuticals. (6/6/11)
  Posted 6/6/11 at 5:47pm via finsmes.com
• 
  SR One invested in Springleaf Therapeutics. (5/12/11)
  Posted 5/12/11 at 12:28am via masshightech.com

Investments

Videos

Sources

1. Effector Therapeutics snags $45M venture round from A-list backers (fiercebiotech.com) [edit]
2. Aileron Therapeutics Raises $12M in Series D Financing (finsmes.com) [edit]
3. River Vision Announces Completion of $17 million Series A Financing (m.prnewswire.com) [edit]
4. Bicycle Therapeutics Raises £3.75M in Funding (finsmes.com) [edit]
5. Applied Genetic Technologies Corporation Lands $37.5 Million in Venture Capital Funding (biospace.com) [edit]
6. Principia Biopharma Secures $12.5M Second Tranche In Series A Financing, Expands Senior Management Team (bizjournals.com) [edit]
7. Thrasos Secures $35 Million to Fund THR-184 Phase 2 Clinical Program for Treatment of Acute Kidney Injury (businesswire.com) [edit]
8. Genocea raises $30M to advance herpes vaccine (masshightech.com) [edit]
9. IlluminOss Medical Secures $28 Million Series C Financing for Minimally Invasive Bone Fracture Repair (marketwire.com) [edit]
10. Auxogyn Raises $18M in Series B Financing (finsmes.com) [edit]
11. RaNA Therapeutics emerges from stealth with $20.7M Series A round (masshightech.com) [edit]
12. MissionTherapeutics Ltd Raises $10 Million, Eyes Rapid Growth (biospace.com) [edit]
13. Nimbus, Seeded by Bill Gates, Raises $24 Million For Computer-Aided Drug Discovery (xconomy.com) [edit]
14. HTG Molecular Diagnostics Receives $500k from SR One in Series D Financing (finsmes.com) [edit]
15. Constellation Pharmaceuticals Raises $15M in Series B Financing (finsmes.com) [edit]
16. SpringLeaf Therapeutics raises $15M Series B round (masshightech.com) [edit]
17. f-star raises €15M in a New Financing led by SR One (f-star.com) [edit]
18. Genocea Biosciences Closes $35M Series B Financing Round (finsmes.com) [edit]
19. SEMPRUS BIOSCIENCES RAISES ADDITIONAL $18 MILLION (semprusbio.com) [edit]
20. VCs inject $29M into Syntaxin, $11.5M into Ceregene (fiercebiotech.com) [edit]
21. Dicerna makes $29M second close on Series B funding round (masshightech.com) [edit]
22. IPierian Announces Second Close Of Series B Financing At $28M (fis.dowjones.com) [edit]
23. Constellation Pharmaceuticals, Inc.: Series B $4.8M (onbiovc.com) [edit]
24. Big Pharma firms back $43M round for NeuroTherapeutics (fiercebiotech.com) [edit]
25. CalciMedica Closes Second Tranche of $12M Series C Financing (finsmes.com) [edit]
26. Trinity Biosystems raises $7.5M bridge to treat endocrine disorders (deals.venturebeat.com) [edit]
27. Aileron Therapeutics Closes Series D Financing (zibb.com) [edit]
28. Anaphore, Inc.: Series A $13M (onbiovc.com) [edit]
29. Rib-X Pharmaceuticals Announces Positive Phase 2 Study Results for Delafloxacin and a $25 Million Financing (rib-x.com) [edit]
30. CalciMedica, Inc.: Series C $4M (onbiovc.com) [edit]
31. Capital Funding Report [edit]
32. Syntaxin Raises $32M to Advance Development of Novel Drug Pipeline (syntaxin.com) [edit]
33. CalciMedica raises $1.5M for inflammatory disease (venturebeat.com) [edit]
34. Onyvax Raises £8 Million to Advance Development of Prostate Cancer Vaccine (onyvax.com) [edit]